Abstract

Endocrine and metabolic disorders can occur in the form of paraneoplastic syndrome and as a consequence of oncological treatment. The most common disorders include hypercalcaemia, ectopic production of vasopressin in the course of cancer, ectopic Cushing's syndrome and secondary osteoporosis. What should be taken into account during the diagnosis of endocrine disorders, is paraneoplastic syndrome that frequently precedes the occurrence of symptoms typical of a particular diagnosis, which could influence the proper orientation of the diagnostic process. During and after anticancer treatment, it is recommended that patients should be monitored for the possible development of acute or chronic metabolic and endocrine disorders which may pose a threat to their life or health.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.